Skip to content
10-Q

Quarterly Report

Atea Pharmaceuticals, Inc. AVIR

0001193125-25-277815

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 10, 2025 78.13M sh
Shares Diluted Q3 2025 · Sep 30, 2025 79.05M sh
Shares Diluted Q3 2025 · Sep 30, 2025 82.62M sh
Shares Diluted Q3 2025 · Sep 30, 2024 84.42M sh
Shares Diluted Q3 2025 · Sep 30, 2024 84.2M sh
Stock Repurchased Q3 2025 · Sep 30, 2025 $25.52M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$103.81M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$105.1M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $77.34M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $64.7M
Stockholders Equity Q3 2025 · Sep 30, 2025 $315.78M
Stockholders Equity Q3 2025 · Jun 30, 2025 $364.42M
Stockholders Equity Q3 2025 · Mar 31, 2025 $411.08M
Stockholders Equity Q3 2025 · Dec 31, 2024 $438.87M
Stockholders Equity Q3 2025 · Sep 30, 2024 $458.52M
Stockholders Equity Q3 2025 · Jun 30, 2024 $476.47M
Stockholders Equity Q3 2025 · Mar 31, 2024 $504.37M
Stockholders Equity Q3 2025 · Dec 31, 2023 $555.19M
Current Liabilities Q3 2025 · Sep 30, 2025 $20.18M
Current Liabilities Q3 2025 · Dec 31, 2024 $18.6M
Total Liabilities Q3 2025 · Sep 30, 2025 $27.18M
Total Liabilities Q3 2025 · Dec 31, 2024 $25.8M
Current Assets Q3 2025 · Sep 30, 2025 $336.14M
Current Assets Q3 2025 · Dec 31, 2024 $462.36M
Total Assets Q3 2025 · Sep 30, 2025 $342.96M
Total Assets Q3 2025 · Dec 31, 2024 $464.67M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.53
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.37
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.37
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.60
Eps Basic Q3 2025 · Sep 30, 2025 −$0.53
Eps Basic Q3 2025 · Sep 30, 2025 −$1.37
Eps Basic Q3 2025 · Sep 30, 2024 −$0.37
Eps Basic Q3 2025 · Sep 30, 2024 −$1.60
Sga Expense Q3 2025 · Sep 30, 2025 $7.22M
Sga Expense Q3 2025 · Sep 30, 2025 $25.75M
Sga Expense Q3 2025 · Sep 30, 2024 $11.04M
Sga Expense Q3 2025 · Sep 30, 2024 $35.49M
Rd Expense Q3 2025 · Sep 30, 2025 $38.35M
Rd Expense Q3 2025 · Sep 30, 2025 $100.21M
Rd Expense Q3 2025 · Sep 30, 2024 $26.16M
Rd Expense Q3 2025 · Sep 30, 2024 $118.43M
Net Income Q3 2025 · Sep 30, 2025 −$42.05M
Net Income Q3 2025 · Sep 30, 2025 −$113.48M
Net Income Q3 2025 · Jun 30, 2025 −$37.16M
Net Income Q3 2025 · Mar 31, 2025 −$34.27M
Net Income Q3 2025 · Sep 30, 2024 −$31.15M
Net Income Q3 2025 · Sep 30, 2024 −$134.84M
Net Income Q3 2025 · Jun 30, 2024 −$40.52M
Net Income Q3 2025 · Mar 31, 2024 −$63.17M
Operating Income Q3 2025 · Sep 30, 2025 −$45.57M
Operating Income Q3 2025 · Sep 30, 2025 −$125.95M
Operating Income Q3 2025 · Sep 30, 2024 −$37.2M
Operating Income Q3 2025 · Sep 30, 2024 −$153.92M